• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于免疫基因组分析的浆液性卵巢癌分类。

Classification of serous ovarian carcinoma based on immunogenomic profiling.

机构信息

Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China.

Department of Gynecology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China.

出版信息

Int Immunopharmacol. 2021 Feb;91:107274. doi: 10.1016/j.intimp.2020.107274. Epub 2020 Dec 21.

DOI:10.1016/j.intimp.2020.107274
PMID:33360087
Abstract

Treatment of serous ovarian cancer (SOC) remains a clinical challenge. Classification of SOC based on immunogenomic profiling is important for establishing immunotherapy strategies. We extracted RNA-seq data of SOC from TCGA-OV. The samples were ultimately classified into high immune (Immunity_H) group and low immune (Immunity_L) group based on the immunogenomic profiling of 29 immune signatures by using unsupervised machine learning methods and modified by multifaceted characterization of immune response. High immune group showed the lower tumor purity and higher anti-tumor immune activity, and the higher expressions of PDCD1, CD274 and CTLA4. Furthermore, the overall survival time and the progression-free interval were significantly longer in high-immun group. The differentially expressed genes were mainly enriched in some immune response related functional terms and PI3K-AKT signaling pathway. According to ImmuCellAI, the abundance of various T cell subtypes in high immune group were significantly higher than those in low immune group. This novel immunotyping shows promise for prognostic and immunotherapeutic stratification in SOC patients.

摘要

浆液性卵巢癌(SOC)的治疗仍然是临床面临的挑战。基于免疫基因组特征对 SOC 进行分类对于制定免疫治疗策略很重要。我们从 TCGA-OV 中提取了 SOC 的 RNA-seq 数据。最终,我们通过无监督机器学习方法并结合免疫反应的多方面特征,根据 29 个免疫特征的免疫基因组特征,将这些样本分为高免疫(Immunity_H)组和低免疫(Immunity_L)组。高免疫组表现出较低的肿瘤纯度和更高的抗肿瘤免疫活性,以及 PDCD1、CD274 和 CTLA4 的高表达。此外,高免疫组的总生存时间和无进展间隔明显更长。差异表达基因主要富集在一些免疫反应相关的功能术语和 PI3K-AKT 信号通路中。根据 ImmuCellAI,高免疫组中各种 T 细胞亚型的丰度明显高于低免疫组。这种新的免疫分型有望为 SOC 患者的预后和免疫治疗分层提供依据。

相似文献

1
Classification of serous ovarian carcinoma based on immunogenomic profiling.基于免疫基因组分析的浆液性卵巢癌分类。
Int Immunopharmacol. 2021 Feb;91:107274. doi: 10.1016/j.intimp.2020.107274. Epub 2020 Dec 21.
2
Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.程序性细胞死亡蛋白-1(PD-1)和PD-配体1(PD-L1)在卵巢高级别浆液性癌的癌细胞及肿瘤浸润淋巴细胞中的表达对预后的影响
Oncotarget. 2016 Jan 12;7(2):1486-99. doi: 10.18632/oncotarget.6429.
3
High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer.高等级浆液性卵巢癌中腺苷通路的高维分析。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001965.
4
A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors.基于特征的胃癌分类方法,可对肿瘤免疫进行分层,并预测对 PD-1 抑制剂的反应。
Front Immunol. 2021 Jun 11;12:693314. doi: 10.3389/fimmu.2021.693314. eCollection 2021.
5
Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.整合免疫基因组尺度分析研究胶质母细胞瘤免疫表型的遗传决定因素。
Front Immunol. 2021 Jun 16;12:557994. doi: 10.3389/fimmu.2021.557994. eCollection 2021.
6
PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma.PD-L1 表达和 CD8+ 肿瘤浸润淋巴细胞在不同类型的输卵管卵巢癌中的表达及其在高级别浆液性癌中的预后价值。
Am J Surg Pathol. 2020 Aug;44(8):1050-1060. doi: 10.1097/PAS.0000000000001503.
7
A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.基于免疫基因组学的透明细胞肾细胞癌新型预后模型。
Int Immunopharmacol. 2021 Jan;90:107119. doi: 10.1016/j.intimp.2020.107119. Epub 2020 Nov 24.
8
Neoantigens and the tumor microenvironment play important roles in the prognosis of high-grade serous ovarian cancer.新抗原和肿瘤微环境在高级别浆液性卵巢癌的预后中发挥重要作用。
J Ovarian Res. 2022 Jan 29;15(1):18. doi: 10.1186/s13048-022-00955-9.
9
B7-H4 expression in ovarian serous carcinoma: a study of 306 cases.B7-H4在卵巢浆液性癌中的表达:306例研究
Hum Pathol. 2016 Nov;57:1-6. doi: 10.1016/j.humpath.2016.06.011. Epub 2016 Jun 24.
10
Clinical significance of the immune microenvironment in ovarian cancer patients.卵巢癌患者免疫微环境的临床意义。
Mol Omics. 2018 Oct 8;14(5):341-351. doi: 10.1039/c8mo00128f.

引用本文的文献

1
Identification and validation of prognostic biomarkers related to tumor immune invasion in pancreatic cancer.胰腺癌中与肿瘤免疫浸润相关的预后生物标志物的鉴定与验证
Front Genet. 2025 Mar 10;16:1556544. doi: 10.3389/fgene.2025.1556544. eCollection 2025.
2
New Achievements from Molecular Biology and Treatment Options for Refractory/Relapsed Ovarian Cancer-A Systematic Review.难治性/复发性卵巢癌的分子生物学新进展及治疗选择——一项系统综述
Cancers (Basel). 2023 Nov 10;15(22):5356. doi: 10.3390/cancers15225356.
3
Comprehensive Approach to Genomic and Immune Profiling: Insights of a Real-World Experience in Gynecological Tumors.
基因组和免疫分析的综合方法:妇科肿瘤真实世界经验的见解
Diagnostics (Basel). 2022 Aug 6;12(8):1903. doi: 10.3390/diagnostics12081903.